Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal

Similar documents
FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

Organizing committee at imed.ulisboa/ffulisboa Joao Goncalves (Coordinator) and Paula Brito.

FCT PhD Programme Medicines and Pharmaceutical Innovation (i3du)

We welcome the participation of external academic and scientific community members. Registration is free but mandatory.

WORKSHOP ON NUCLEAR MOLECULAR IMAGING

Curriculum vitae. Research Gate:

BioNanoMed March, Krems/Austria

Post-Baccalaureate Program in Pharmaceutical Science. Accelerate your career

The EIMPack Project. The Economic Impact of the Packaging and Packaging Waste Directive

BioNanoMed March, Krems/Austria

NOVEL DRUG DELIVERY SYSTEMS II

training programme in pharmaceutical medicine clinical pharmacology

Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more:

REIMAGINING DRUG DEVELOPMENT:

Drug Discovery and Development November 02-03, 2017 Chicago, USA

PROFESSOR VINESS PILLAY & DR. YAHYA E. CHOONARA Department of Pharmacy and Pharmacology at the University of the Witwatersrand

Nanoparticles in Life Sciences and Biomedicine

The National Institutes of Health ICs: mission and funding strategies

REPORT SYMBIOCARE: PORTUGAL INNOVATIVE MODELS FOR EFFICIENT HEALTH AND CARE

training programme in pharmaceutical medicine Translational MEDICINE

ICSPORTS th International Conference on Sport Sciences Research and Technology Support

NanoAssemblr Benchtop. Develop Future Nanomedicines

Healthcare. Healthcare. The Centre for Process Innovation. From innovation to commercialisation

Recent years have witnessed an unprecedented

Research Day. School of Pharmacy & Pharmaceutical Sciences

MODULE 3 Preclinical safety May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES

The Aptuit Center for Drug Discovery & Development Verona, Italy

Successful Academia-Pharma Collaboration Drug Discovery and Clinical Development

OVERVIEW. ibet MISSION AND OBJECTIVES

P R A C T I C A L INFORMATION

KRISANI BIO SCIENCES PVT. LTD.

Cancer Nanotechnology and Nanotoxicology: Response to NIH RFAs

Impact Factor: an appropriate criterion for the Qualis journals classification in the Pharmacy area?

MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery

The Impact of Pharmaceutical Sciences on Healthcare Vinod P. Shah, Ph.D., Pharmaceutical Consultant

QPS Neuropharmacology Overview

On the complexity of production planning and scheduling in the pharmaceutical industry: the Delivery Trade-offs Matrix

From Discovery to Development of new Drugs. and pitfalls along the way. by Kim Dekermendjian, PhD in Medicine BD & Key Account manager

Nanotechnology and Advanced Materials for more effective Healthcare

Drug Delivery Innovation Center INVITE. 5 October 2017

Preliminary scientific programme

Technical Report No. 63 Quality Requirements for the Extemporaneous Preparation of Clinical Trial Materials

MASTER IN PHARMACEUTICAL SCIENCES (Thesis Track)

Drug Delivery Innovation Center INVITE. 9 April 2018

IMMUNOTHERAPY 2008: IMPLEMENTING COMBINATIONS

A unique Collaborative Model for the Discovery of New Therapeutic Approaches

Pharmacy. i3l PHARMACY BACHELOR PROGRAM. The architect of drugs. Improving the Quality of Life

Oxford Nanomedicine Summer School 29 June 3 July Nanotechnologies for Medicine and Healthcare

2 nd Alqueva Summer School on Atmospheric and Inland Water Sciences Alqueva, June 2018

Eleventh Annual Chapel Hill Pharmaceutical Sciences Conference. Pharmacy in the Era of Precision Medicine: From Discovery to Implementation

Translational Medicine From Discovery to Health

training programme in pharmaceutical medicine clinical development

NOVEL APPROACHES FOR GLYCOCONJUGATION

Multidisciplinary master and doctoral programmes at the University of Lisbon

Overview of comments received on IMI Advanced Therapies Concept Paper

Partnership Opportunities with the Frederick National Laboratory

Biomedical Sciences Graduate Program

3rd Oral Drug Formulation Innovations June 26-27, 2019 Philadelphia, PA

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

The Irish Biomarker Network - Inaugural Workshop Improved Translation of Biomarkers to the Clinic

Personalized. Health in Canada


Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date

Project management The basics

The Power to Cure: Therapeutic Innovation in Academia

Fast Track Drug Development The Clinical (Caleidoscopic) Perspective

Centre for Bioactive Molecules and Drug Delivery (BMDD)

Creative product design using biomimetics

FUTURE MEANS CREATIVITY

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

Advanced Biomaterials and Nanotechnologies in Drug Delivery

National Measurement Laboratory Designated Institute for chemical and bio-measurement

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues

EXPERT COLLECTION. Explore our leading medical review series

9:15-9:30 WELCOME Paula Alves (Conference Chair) & Lino Ferreira (SPCE-TC President)

Scientific Program. Thursday, November 16

Life SCIENCE GR ADUATE SCHOOL OF

'PHARMACOLOGY%20%26%20PHARMACY'

Pharmaceutical Sciences/Pharmacodynamics, M.S.

Fostering Convergent Scientific Research and Industry Engagement in a University Setting: Challenges and Strategies

Peptides Tales of Peptides Proceedings of the Thirty-First European Peptide Symposium. September 5-9, 2010, Copenhagen, Denmark

Contents 1 Nanotechnology and Its Drug Delivery Applications

PhD OPEN POSITIONS Initial Call

Recent years have witnessed an expansion in the disciplines encompassing drug

Ondaplanetária Presentation

Comparative Oncology Program

Role of Academic Investigators in Drug Development

We make drugs smarter

COURSE GUIDE Universidad Católica de Valencia Pharmaceutical Engineering and Drug Design THIS SUBJECT IS NOT OFFERED DURING THIS ACADEMIC YEAR

Faculty : Pharmacy Department: Pharmaceutical Sciences and Pharmaceutics Academic Year: Semester : Second ( Course Syllabus )

What IMI means for POLAND

Translational Research through Public-Private Partnerships. 65 th Annual Bohan Lecture. Scott J. Weir, PharmD, PhD 08 October 2011

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

Dr. Samer R. Abulateefeh

Program outcomes MPHARM. Demonstrate understanding of basic sciences relevant to specialty.

Evonik Birmingham Laboratories

INNOVATIVE SOLUTIONS IN THE PHARMACEUTICAL INDUSTRY

Nanoparticles for Early Diagnostics of Inflammatory Diseases: new approaches in the field of soft and hard nanoparticles

Innovative Medicines Initiative (IMI) and other Public Private Partnerships: Educational Ambitions

Transcription:

PhD Programme in Medicines and Pharmaceutical Innovation Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal Organizing committee at imed.ulisboa/ffulisboa António Almeida (Coordinator) Helena Florindo The FCT PhD Programme in Medicines and Pharmaceutical Innovation (i3du; http://www.ff.ul.pt/phd3duul/) trains students in target discovery, drug design, preclinical development, and drug safety, bridging the translational gap from discoveries on disease targets and mechanisms into novel diagnostic and therapeutic agents. The Course on Advanced Drug Delivery is part of the PhD Programme in Medicines and Pharmaceutical Innovation (i3du), trains students in the development of advanced medicinal products, covering crucial aspects that determine the fate of drugs in the human or animal body, from their fundamentals to the advanced strategies to overcome the physiological barriers, including innovative technological and therapeutic applications. The course will be held at the Research Institute for Medicines (imed.ulisboa), Faculdade de Farmácia, Universidade de Lisboa, in Lisbon, 3-7 July 2017. The training program is aimed at PhD students, but welcomes the participation of external academic and scientific community members. Registration (https://goo.gl/uursog) is free but mandatory. Programme Drug delivery technology is becoming increasingly sophisticated involving several approaches and issues such as pharmacokinetics, drug biodistribution, drug targeting to its site of action (site-specific drug delivery), nanomedicines, nanotoxicology, etc. Therefore, advanced drug delivery is a crucial component of any PhD programme involving the discovery, design, development and usage of medicines. It is an area in which students from many different scientific backgrounds must have proper training and understanding. The course is intended to improve the understanding of advanced medicinal products, covering relevant aspects that determine the fate of drugs in the human or 1

animal body, from their fundamentals to the advanced strategies to overcome the physiological barriers, including innovative technological and therapeutic applications. It aims at explaining the principles underlying the development of advanced drug delivery systems as well as pointing future trends in this field. 3 July 2017 1. Drug Delivery Fundamentals 09:30h Drug Delivery: Quo Vadis? José Morais, Research Institute for Medicines (imed.ulisboa), Faculty 10:20h Discussion 11:00h Pharmacokinetics in advanced drug delivery Rosário Lobato, 12:10h Lunch Break 2. Overcoming Biological Barriers 14:00h Oral delivery of biopharmaceuticals Francisca Araújo, Instituto de Investigação e Inovação em Saúde (i3s), Universidade do Porto 15:10h Overcoming the skin barrier Sandra Simões, Research Institute for Medicines (imed.ulisboa), 4 July 2017 2. Nanoparticulate Delivery Systems 10:00h Nanotoxicology: implications for advanced drug delivery systems development Ana Francisca Bettencourt, Research Institute for Medicines (imed.ulisboa), 10:50h Discussion 11:10h Liposomes: Present and future of the first nanopharmaceutical dosage form Eugénia Cruz, Research Institute for Medicines (imed.ulisboa), 2

12:00h Discussion 12:20h Lunch Break 14:00h Lipid nanoparticles: formulation development and safety aspects Eliana Souto, Faculty of Pharmacy, Universidade de Coimbra 15:10h Taking the most from nanotechnology-based drug delivery in anticancer therapy João Nuno Moreira, Faculty of Pharmacy and Center for Neurosciences and Cell Biology (CNC), Universidade de Coimbra 5 July 2017 3. Delivery Systems in Theranostics 09:30h Biodistribution of nanoparticulate drug delivery systems António Rocha Paulo, Instituto Superior Técnico, Campus Tecnológico e Nuclear, Universidade de Lisboa 10:10 h Discussion 10:25h Coffee break 10h45h 11h25h 11h35h 12h15h In-vivo molecular imaging using PET-MRI Pedro Almeida, Instituto de Biofísica e Engenharia Biomédica (IBEB), Faculty of Sciences, Universidade de Lisboa Discussion Molecular interactions probed by AFM-based force spectroscopy Nuno Santos, Instituto de Medicina Molecular (IMM), Faculty of Medicine, Universidade de Lisboa Discussion 12:30h Lunch Break 14:30h Targeting Drug Conjugates: An emerging strategy for drug delivery Pedro Góis, Research Institute for Medicines (imed.ulisboa), Faculty 15:10h Discussion 15:25h Funtional nanoparticles for MRI: diagnostic and therapy applications Bárbara Martins, Research Institute for Medicines (imed.ulisboa), 3

16:15h Discussion 6 July 2017 4. Innovative Technological Applications 09:30h Biotherapeutics below the freezing temperature, unveiling thermo-stability and accelerating formulation by cold Miguel Angelo Rodrigues, Centro de Química Estrutural, Instituto Superior Técnico, Universidade de Lisboa 12:20h Discussion 11:00h From in silico identification of proteasome inhibitors to in vivo application Rita Guedes, Research Institute for Medicines (imed.ulisboa), 12:10h Lunch Break 14:00h Spray-drying technology for targeted pulmonary delivery Ana Grenha, Centre for Biomedical Research, Universidade do Algarve 15:10h PAT tools towards translational advanced drug delivery João Lopes, Research Institute for Medicines (imed.ulisboa), Faculty 7 July 2017 5. Drug Delivery Strategies 09:30h Industrial perspectives on the use of predictive biopharmaceutics tools Mark McAllister, Drug Delivery Group Leader, Research Formulation, Pfizer Group R&D, UK 10:20h Discussion 4

11:00h Viral and non-viral gene therapy approaches for neurodegenerative disease treatment Luís Almeida, Center for Neurosciences and Cell Biology (CNC) and Faculty of Pharmacy, Universidade de Coimbra Assessment (i3du 1 st Year PhD students ONLY) Assessment of the course consists in the preparation and submission of a research project, 10 000 characters long (including spaces). Students are grouped to build multidisciplinary teams. Each group works throughout the week on a research project that should reflect the topic of the course, including methodologies and strategies to solve an innovative research question. The project is expected to adhere to the following general structure: a) Title; b) Conceptual hurdle and innovative idea to be tested; c) Plan and methods: d) Relevance of the project (scientific and social impact). The students will select a broad topic of research and are expected to propose a specific project. This project will be evaluated according to the following criteria and weight: a) Novelty and relevance (30%); b) approach to the problem (30%); c) multidisciplinarity of the research plan (40%). Students will attend a workshop on How to write a research project. Specific slots are allocated in the course programme for group discussions, which will take place in prebooked rooms. 5